Factors Associated With Underutilization of Antiviral Therapy in Preventing Hepatitis B Virus-Related Hepatocellular Carcinoma

IF 6.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Alimentary Pharmacology & Therapeutics Pub Date : 2025-06-07 DOI:10.1111/apt.70224

Jia-Ling Wu, Ying-Nan Tsai, Cheng-Hao Tseng, Shang-Chen Tseng, Chih-Wen Lin, Chih-Lung Hung, Mindie H. Nguyen, Jaw-Town Lin, Yao-Chun Hsu

引用次数: 0

Abstract

Deaths from hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) are projected to increase through 2030. Underutilisation of antiviral therapy may contribute to this concerning trend but empirical data remain sparse.

Abstract Image

查看原文本刊更多论文

预防乙型肝炎病毒相关肝细胞癌抗病毒治疗未充分利用的相关因素

预计到2030年，乙型肝炎病毒（HBV）相关肝细胞癌（HCC）的死亡人数将增加。抗病毒治疗的利用不足可能导致这一令人担忧的趋势，但经验数据仍然很少。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.